PMID- 29601578 OWN - NLM STAT- MEDLINE DCOM- 20180709 LR - 20181114 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 13 IP - 3 DP - 2018 TI - HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation. PG - e0194185 LID - 10.1371/journal.pone.0194185 [doi] LID - e0194185 AB - Interleukin-18 (IL-18) is a pleiotropic cytokine of the IL-1 family with multiple context dependent functions. We and others have shown that HIV infection is accompanied by increased circulating levels of IL-18 along with decreased levels of its antagonist, Interleukin-18 Binding Protein (IL-18BP). The infection is also accompanied by intestinal inflammation and decreased intestinal integrity as measured by intestinal permeability, regeneration and repair. However, little is known concerning the relation between high level of IL-18 associated with the viral infection and intestinal permeability. Here we demonstrate that HIV treatment increases production of IL-18 and decreases that of IL-18BP production in human intestinal epithelial cell (IEC) lines. IL-18 causes apoptosis of the IEC by activating caspase-1 and caspase-3. It induces epithelial barrier hyperpermeability by decreasing and disrupting both tight and adherens junction proteins, occludin, claudin 2 and beta-catenin. Disorganization of F-actin was also observed in the IEC that were exposed to the cytokine. Moreover IL-18 decreases transepithelial electrical resistance (TEER) in Caco-2 and increases permeability in HT29 monolayers. The cells' treatment with IL-18 causes an increase in the expression of phosphorylated myosin II regulatory light-chain (p-MLC) and myosin light-chain kinase (MLCK), and a decrease in phosphorylated Signal Transducer and Activator of Transcription (p-STAT)-5. This increase in p-MLC is suppressed by a Rho-kinase (ROCK)-specific inhibitor. Interestingly, the levels of the cytokine correlate with those of LPS in the circulation in three different categories of HIV infected patients (HAART-naive and HAART-treated HIV-infected individuals, and Elite controls) as well as in healthy controls. Collectively, these results suggest that the HIV-induced IL-18 plays a role in increased intestinal permeability and microbial translocation observed in HIV-infected individuals. FAU - Allam, Ossama AU - Allam O AD - Laboratory of Innate Immunity, CHU Ste-Justine Research Center/Department of Microbiology, Infectious Diseases & Immunology, University of Montreal, Montreal, Quebec, Canada. FAU - Samarani, Suzanne AU - Samarani S AD - Laboratory of Innate Immunity, CHU Ste-Justine Research Center/Department of Microbiology, Infectious Diseases & Immunology, University of Montreal, Montreal, Quebec, Canada. FAU - Mehraj, Vikram AU - Mehraj V AD - Division of Hematology & Chronic Viral Illness Service, McGill University, Montreal, Quebec, Canada. FAU - Jenabian, Mohammad-Ali AU - Jenabian MA AD - Department of Biological Sciences, UQAM, Montreal, Quebec, Canada. FAU - Tremblay, Cecile AU - Tremblay C AD - CHUM/ Department of Microbiology, Infectious Diseases & Immunology, University of Montreal, Montreal, Quebec, Canada. FAU - Routy, Jean-Pierre AU - Routy JP AD - Division of Hematology & Chronic Viral Illness Service, McGill University, Montreal, Quebec, Canada. FAU - Amre, Devendra AU - Amre D AD - CHU Ste-Justine Research Center/Department of Pediatrics, University of Montreal, Montreal, Quebec, Canada. FAU - Ahmad, Ali AU - Ahmad A AUID- ORCID: 0000-0001-7689-7115 AD - Laboratory of Innate Immunity, CHU Ste-Justine Research Center/Department of Microbiology, Infectious Diseases & Immunology, University of Montreal, Montreal, Quebec, Canada. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180330 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Interleukin-18) RN - 0 (interleukin-18 binding protein) SB - IM MH - *Bacterial Translocation MH - Caco-2 Cells MH - Epithelial Cells/*metabolism/microbiology/pathology/virology MH - Female MH - HIV Infections/*metabolism/microbiology/pathology MH - HIV-1/*metabolism MH - Humans MH - Intercellular Signaling Peptides and Proteins/metabolism MH - Interleukin-18/*biosynthesis MH - Intestinal Mucosa/*metabolism/microbiology/pathology/virology MH - Male MH - Permeability PMC - PMC5877838 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2018/03/31 06:00 MHDA- 2018/07/10 06:00 PMCR- 2018/03/30 CRDT- 2018/03/31 06:00 PHST- 2017/06/19 00:00 [received] PHST- 2018/02/26 00:00 [accepted] PHST- 2018/03/31 06:00 [entrez] PHST- 2018/03/31 06:00 [pubmed] PHST- 2018/07/10 06:00 [medline] PHST- 2018/03/30 00:00 [pmc-release] AID - PONE-D-17-23252 [pii] AID - 10.1371/journal.pone.0194185 [doi] PST - epublish SO - PLoS One. 2018 Mar 30;13(3):e0194185. doi: 10.1371/journal.pone.0194185. eCollection 2018.